Nationwide Fund Advisors’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Nationwide Fund Advisors’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-17,030	Closed	-$356K	–	3269
2016 Q3	$356K	Sell	17,030 -29,507	-63%	-$340K	﹤0.01%	2340
2016 Q2	$502K	Buy	46,537 +8,004	+21%	+$68.5K	﹤0.01%	2149
2016 Q1	$255K	Sell	38,533 -1,500	-4%	-$13.6K	﹤0.01%	2422
2015 Q4	$725K	Sell	40,033 -16,025	-29%	-$221K	﹤0.01%	1898
2015 Q3	$617K	Buy	56,058 +47,525	+557%	+$505K	﹤0.01%	1979
2015 Q2	$123K	Buy	8,533 +3,679	+76%	+$50K	﹤0.01%	2950
2015 Q1	$57K	Buy	4,854 +776	+19%	+$10.5K	﹤0.01%	3080
2014 Q4	$68K	Buy	+4,078	New	+$59.6K	﹤0.01%	2992

Nationwide Fund Advisors's VTAE Position: Q4 2016 in Review

Nationwide Fund Advisors sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 17,030 shares — an estimated $356K sold.

Nationwide Fund Advisors first reported a position in VTAE in Q4 2014 and held it in 8 quarters. The position peaked at $725K in Q4 2015. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Nationwide Fund Advisors reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Nationwide Fund Advisors sold 17,030 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $356K.
Nationwide Fund Advisors first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 8 quarters.
Nationwide Fund Advisors's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $725K in Q4 2015.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Nationwide Fund Advisors's 13F filing for Q4 2016, filed 27 Jan 2017.